DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lin NU, Murthy RK, Anders CK. et al.
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB).
J Clin Oncol 2020;
38: 1005-1005
We do not assume any responsibility for the contents of the web pages of other providers.